Retrospective Analysis of Repeat Kidney Biopsy Outcomes in 19 Pediatric Lupus Nephritis Patients

This retrospective cohort study included 19 pediatric lupus nephritis patients aged 5 to 18 years. The research was conducted at Nanjing Children's Hospital during a period spanning from 2009 to 2022. The primary exposure investigated was repeat kidney biopsy, while no comparator group was reported. The study aimed to assess pathological evolution, therapeutic implications, and prognostic impact as secondary outcomes.

Specific main results were not reported in the provided data. Consequently, quantitative data regarding pathological changes or clinical outcomes associated with repeat kidney biopsy are unavailable. The follow-up duration was also not reported, limiting the assessment of long-term effects. Because the main results field is empty, no statistical significance or effect sizes can be derived from this evidence.

Safety and tolerability data were not reported. There were no adverse events, serious adverse events, or discontinuations documented in the input. Similarly, no funding sources or conflicts of interest were reported. The study design is observational, which precludes causal inferences regarding the intervention.

Key limitations include the sample size of 19 patients and the retrospective nature of the cohort. The lack of reported primary outcomes and follow-up duration further restricts clinical interpretation. Practice relevance was not reported, and the certainty of the evidence remains uncertain. Clinicians should recognize the incomplete data profile when considering this information for patient care decisions.

This summary reflects the available structured evidence without extrapolating beyond the provided input. The absence of reported results necessitates caution in applying these findings to broader clinical settings. The certainty of the evidence remains uncertain based on the provided data.